NCT06405308Completed
Robotic Natural Orifice Specimen Extraction Surgery Versus Robotic Transabdominal Specimen Extraction Surgery for Early-Stage Rectal Cancer
Robotic Natural Orifice Specimen Extraction Surgery Versus Robotic Transabdominal Specimen Extraction Surgery for Rectal Cancer: a Multicentre Propensity Score-Matched Analysis
Source: ClinicalTrials.gov · Last updated 13 May 2024
Brief summary (registry, in English)
A retrospective cohort study, conducted nationwide（China） and across multiple centers, aimed to compare the surgical quality and short-term outcomes of R-NOSES （robotic natural orifice specimen extraction surgery）with R-TSES （robotic transabdominal specimen extraction surgery） for early-stage rectal cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 636 (actual)
- First submitted
- 4 May 2024
- Start date
- 1 Oct 2023
- Primary completion date
- 15 Jan 2024
- Lead sponsor
- Taiyuan Li
- Diseases
- Colorectal cancer
- NCT number
- NCT06405308
What you commit to
- Study type: Observational
- Participants enrolled: 636
- From 1 Oct 2023 to the primary completion date, 15 Jan 2024
- 8 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR)
Other illness
- history of abdominal surgery
- history of pelvic surgery
- presence of another primary cancer
- anal or vaginal disease
Other
- body mass index (BMI) ≥ 35 kg/m2
- ileostomy or transverse colostomy
- conversion to open operation
- tumor distant metastasis
Who the study is looking for
- histologically confirmed rectal adenocarcinoma
- robotic TME for rectal adenocarcinoma
- postoperative pathological staging of T1-2N0M0
- complete surgical and postoperative follow-up information
Age in the registry: 20 years to 86 years · Sex: All · Does not accept healthy volunteers
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| The Second Xiangya Hospital of Central South University Coordinator of this site? Confirm its status | Changsha | China | Unknown status |
| Three Gorges Hospital Affiliated to Chongqing University Coordinator of this site? Confirm its status | Chongqing | China | Unknown status |
| Fujian Cancer Hospital Coordinator of this site? Confirm its status | Fuzhou | China | Unknown status |
| The Second Affiliated Hospital of Harbin Medical University Coordinator of this site? Confirm its status | Harbin | China | Unknown status |
| The First Affiliated Hospital of NanChang University Coordinator of this site? Confirm its status | Nanchang | China | Unknown status |
| Zhongshan Hospital,Fudan University Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
| The First Affiliated Hospital of Zhengzhou University Coordinator of this site? Confirm its status | Zhengzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.